AMC 4
Alternative Names: AMC-4Latest Information Update: 03 Mar 2023
At a glance
- Originator ARScience Bio
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 21 Feb 2023 Early research in Solid tumours in USA, prior to February 2023 (ARScience Bio pipeline, February 2023)